Pathogenicity assessment of genetic variants identified in patients with severe hypertriglyceridemia: Novel cases of familial chylomicronemia syndrome from the Dyslipidemia Registry of the Spanish Atherosclerosis Society
- 24 January 2025
- journal article
- Published by Elsevier in Genetics in Medicine
- Vol. 27 (5) , 101365
Abstract
No abstract availableKeywords
Funding Information
- Regional Government of Andalucia Department of Health and Families Progress and Health Foundation (PIN-0180-2018)
- Government of Andalusia (CTS-159)
- Swedish Orphan Biovitrum AB publ
- Suomen Kardiologinen Seura
- Hospital universitario la paz
- Fundación General Universidad de La Laguna
This publication has 43 references indexed in Scilit:
- ClinGen guidance for use of the PP1/BS4 co-segregation and PP4 phenotype specificity criteria for sequence variant pathogenicity classificationThe American Journal of Human Genetics, 2023
- Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteriaThe American Journal of Human Genetics, 2022
- Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelinesHuman Mutation, 2020
- Overview of Specifications to the ACMG/AMP Variant Interpretation GuidelinesCurrent Protocols in Human Genetics, 2019
- Volanesorsen: First Global ApprovalDrugs, 2019
- Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterionHuman Mutation, 2018
- Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score”Atherosclerosis, 2018
- Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemiaAtherosclerosis, 2015
- Modulation of phenotypic expression of APOA5 Q97X and L242P mutationsAtherosclerosis, 2009
- Familial lipoprotein lipase (LPL) deficiency: A catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and ItalyHuman Mutation, 1997